In contrast, Bowman et al. used a cDC1-specific mouse model to more directly demonstrate that cDC1 are essential for an ICB-mediated immune response against GL261 and CT2A murine GBM tumors [50]. The gene discussed is MPPE1; the disease is glioblastoma.